Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-04
1992-10-27
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3141
Patent
active
051589680
ABSTRACT:
This invention relates to the use of 3-aryl-5-alkylthio-4H-1,2,4-triazoles and the corresponding alkylsulfinyl- and alkylsulfonyl-4H-1,2,4-triazoles in the treatment of patients suffering from chronic hyperreflexia due to spinal trauma.
Kane John M.
Kehne John H.
Miller Francis P.
Friedman S. J.
Merrell Dow Pharmaceuticals Inc.
Simmons Edlyn S.
LandOfFree
3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperrefl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperrefl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-aryl-5-alkylthio-4H-1,2,4-traizoles for treatment of hyperrefl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905785